We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Faces Sanctions In Seroquel MDL

Law360 (August 21, 2007, 12:00 AM EDT) -- The Florida court overseeing multidistrict products liability litigation over AstraZeneca LP's anti-psychotic drug Seroquel has ruled that the pharmaceutical company engaged in sanctionable conduct, granting in part a motion that accused the drug company of failing to comply with discovery obligations.

U.S. Magistrate Judge David A. Baker on Tuesday signed off on a 28-page order, finding that sanctions against AstraZeneca were warranted, and that AstraZeneca had been “purposefully sluggish” in making effective production to the plaintiffs.

Because the court had insisted on a tight schedule, “this...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.